No Prescription |
 |
 | ||
|
Prescription Drugs 8 |
|
| ||
No Prescription » Prescription Drugs 8
Flutinap Nasal Spray Flixonase Flutivate Skin Ointment Cutivate FML Liquifilm Eye Drops Generic Fluorometholone Foracort CFC Free Inhaler Symbicort Fucidin Cream Generic Fusidic acid Fucidin Ointment Generic Fusidic acid Fucithalmic Eye Ointment Generic Fusidic Acid Glucotrol XL Generic Glipizide Heartcare Plus for Large dogs 23 to 45kg Heartgard Plus Heartcare Plus for Medium dogs 12 to 22kg Heartgard Plus Heartcare Plus for Small dogs Upto 11kg Heartgard Plus
No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
|
|
|